MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort. - Wikidata - wikimedia - TriplyDB

MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

http://www.wikidata.org/entity/Q40108065

about

Molecular biology of lung cancer Molecular biology of lung cancer: clinical implications Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?Biomarker development in MET-targeted therapy Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC Role of mesenchymal-epithelial transition amplification in resistance to anti-epidermal growth factor receptor agents Molecular pathology of non-small cell lung cancer: a practical guide.Molecular pathology of lung cancer: key to personalized medicine.The role of HGF/c-MET signaling pathway in lymphoma Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK Selection and evaluation of new reference genes for RT-qPCR analysis in Epinephelus akaara based on transcriptome data Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib.Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.ALK-rearrangements and testing methods in non-small cell lung cancer: a review Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor.Targeting MET Amplification as a New Oncogenic Driver.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Increased MET Gene Copy Number but Not mRNA Level Predicts Postoperative Recurrence in Patients with Non-Small Cell Lung Cancer Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib Mechanisms of resistance to EGFR TKIs and development of a new generation of drugs in non-small-cell lung cancer.The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical Aspects Activating MET kinase rearrangements in melanoma and Spitz tumours.Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations Targetable "driver" mutations in non small cell lung cancer.Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit.Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients.Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer.Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.Genetic and biochemical alterations in non-small cell lung cancer.MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition High MET gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma MET as a possible target for non-small-cell lung cancer.Alterations in EGFR and related genes following neo-adjuvant chemotherapy in Chinese patients with non-small cell lung cancer Personalizing therapy in advanced non-small cell lung cancer Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma.Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping

P2860

Q24606677-058A0D1F-B9F5-428E-A3EE-0DE0378466EF Q24610335-8943A5B0-2D10-42EF-9A57-259C6A2C9F91 Q26748581-299FA2DA-D59C-4F48-B75A-8A2DD5E709B3 Q26751332-6E025A07-3476-428F-8392-6CD930E29C12 Q27025970-E20DB581-A983-4432-81FE-274A4E57CBA1 Q27027957-E37435E3-0DF3-45FD-B17D-C719C45A3A8A Q27690919-ACE2996B-E1FC-4F06-8436-2B84D5082445 Q27691299-18272B56-C6C5-494D-92E0-D5F70D23995D Q28069836-82D7FE77-E8B5-4C0B-BF99-A2F08FAB0CC0 Q28083446-B32DFDC2-CC2B-4BE7-988E-81AECD9E9810 Q31160716-7B9CF979-E5FA-4249-B7B5-E6567979E737 Q33161299-A6369D46-C680-4739-B4EB-E79080B383C9 Q33769437-9285565C-1A93-4FE3-A4A1-8A075659A51A Q33776835-25E31485-440A-4FB9-9784-117BA744FEEF Q34158153-07835FB4-03B5-42CB-8275-33921A8B3032 Q34309927-8FA83823-43CE-45CD-B2CE-CD10A4150868 Q34404209-04B977ED-8DD7-4EC9-830C-07677C96D1A2 Q34478374-8E2B3C17-27A4-426E-AA57-7EB373E758E8 Q34635475-889D2ABD-3781-47FA-9210-15D57370DA83 Q35043706-284CF403-55D8-41FC-9CA3-2CDCCAAA658D Q35078950-73E1446A-DCED-4F84-BA72-1DC6A1407C31 Q35658282-5EC6620C-7498-47AA-921C-C8A42B79A0F4 Q35712214-78600870-F34F-4417-BEDF-3DDB026ECAEA Q35737325-36F84B88-DFF2-4DEB-98BF-4BB3601FCEAF Q35831012-6062FDEE-0882-43C0-97AD-A4B07FAB9E5C Q35858331-247AA9C4-CE23-4DB0-870E-BFB91E16BFBB Q35861046-E8C1E7FB-9BA7-49E7-8556-91CB6F6DE561 Q35896530-60645DD3-7FA4-4323-A8F8-ECA76C5AC86B Q35926926-59021546-6E67-42A2-83FE-063CED8A4C73 Q35983145-295BA43D-AA72-4595-90E6-291B8DB293B0 Q36135757-3968B318-83A9-4A2F-BF42-29C60D53AF0E Q36184584-E9DB56E6-7E14-44D5-8C53-8093E37A8F12 Q36265149-C534ECB7-D2C3-4C98-AF11-C9E6DF41ADEE Q36646078-F7493447-94DC-4B70-BF90-7845F5AB8AB0 Q36660673-D624C619-C9EA-4BAE-86F2-D483DFEB4E3F Q36669872-E1C0DE58-682D-4AAF-A1EA-EEF640648409 Q36811453-A32A954E-6449-42EA-A9FC-EF94B586C2F6 Q36878125-9C4A97E9-E0E1-4BA7-ADF3-4F387FD5DCB4 Q37051546-4710CA89-5B93-4A67-9ACA-AE73AA777828 Q37141952-1306DFBD-94A8-4419-A089-01A4D6868B92

P2860

MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

http://www.wikidata.org/entity/Q40108065

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

MET gene copy number in non-sm ...... kinase inhibitor naïve cohort.

@en

type

label

MET gene copy number in non-sm ...... kinase inhibitor naïve cohort.

@en

prefLabel

MET gene copy number in non-sm ...... kinase inhibitor naïve cohort.

@en

P1433

Q40108065-251A574A-346B-4FF4-BD62-FC6A8FC6101F

P1476

Q40108065-48E0584A-1E3E-4E16-A067-434C5D9E430E

P2093

Q40108065-0A07C95D-743C-49BA-A3C5-8302FF56DE07

Q40108065-126F6133-B1DF-46DA-A4D6-E22566701EDD

Q40108065-2744AB7F-B425-412D-B63F-4F6FE1C47A12

Q40108065-3AA4DF74-2AEE-4948-B488-1A00D9A36938

Q40108065-3DAA051A-7ABF-428A-8964-F9CB27038068

Q40108065-452EA1D2-E259-4DF4-96F2-FBB3916EAF89

Q40108065-4A66ED9A-B134-4B89-B0AA-6816FAB33904

Q40108065-73E30E5B-8FE3-462B-A40E-7F0C70187369

Q40108065-8F05AB7F-C36D-462D-A981-A94218926EF6

Q40108065-96D70E90-6C15-4598-9889-7F0250E70AD1

P304

Q40108065-34E6210F-D571-4854-9B4A-ED53447160C4

P31

Q40108065-7F0654A5-7540-4E29-AC51-E4FBDB8F782B

P356

Q40108065-95D00464-2939-4E54-9B11-4FE590390337

P433

Q40108065-8AA37893-3E79-46DF-A8BF-89033DB9FF58

P478

Q40108065-C1944682-5F63-4019-8014-D0D8611E434C

P50

Q40108065-4551FCF9-943B-4A3B-BDA9-96A7204FCA51

Q40108065-5A87196E-44DD-4EB4-B8BB-AE7D7BE00D0F

P577

Q40108065-ABB9794F-28D6-4D2B-8476-4238E2FABE87

P698

Q40108065-8837EB2D-EE35-417B-A562-10650702D9E9

P356

JTO.0B013E318168D9D4

P1433

Journal of Thoracic Oncology

P1476

MET gene copy number in non-sm ...... kinase inhibitor naïve cohort

@en

P2093

Agnès Neuville

http://www.w3.org/2001/XMLSchema#string

Anne-Claire Voegeli

http://www.w3.org/2001/XMLSchema#string

Anne-Marie Ruppert

http://www.w3.org/2001/XMLSchema#string

Bertrand Mennecier

http://www.w3.org/2001/XMLSchema#string

Elisabeth Quoix

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Wihlm

http://www.w3.org/2001/XMLSchema#string

Marie P Gaub

http://www.w3.org/2001/XMLSchema#string

Michèle Beau-Faller

http://www.w3.org/2001/XMLSchema#string

Michèle Legrain

http://www.w3.org/2001/XMLSchema#string

Nicolas Meyer

http://www.w3.org/2001/XMLSchema#string

P304

331-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JTO.0B013E318168D9D4

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Gilbert Massard

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18379349

http://www.w3.org/2001/XMLSchema#string